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The present study aimed to evaluate in vivo and in vitro the antitumoural activity of a propolis extract
obtained with edible vegetable oil and its fractions and also to investigate its chemical composition by
LC–MS and LC–MS/MS. To evaluate the toxicological aspects related to the propolis extract treatment,
hematological, biochemical, histopathological and morphological analyses of treated animals were per-
formed. All propolis extracts showed an in vivo antitumour activity in the experimental model with a
moderate toxicity effect at experimental exposure levels. The oil extract was as effective as the ethanolic
extract at inhibiting tumour growth. In vitro assays showed that the whole oil extract produced better
inhibition of tumour cells than its fractions. LC–MS and LC–MS/MS identiﬁed four phenolic acids and
three ﬂavonoids. The anticancer potential of the oil extract of propolis has been demonstrated and the
edible vegetable oil was shown as an attractive alternative solvent to extract bioactive natural propolis
components.
 2010 Elsevier Ltd.Open access under the Elsevier OA license. 1. Introduction
The use of propolis is ancient in traditional medicine dating
back at least to 300 BC (Ghisalberti, 1979). Today, this resinous
bee product continues to be used worldwide, and a broad spectrum
of biological activities for propolis has been reported, including
anticancer, antioxidant, anti-inﬂammatory, antibiotic, and anti-
fungal activities (Burdok, 1998; Marcucci, 1995). The biological
effect of propolis is attributed to its natural bioactive chemicals,
such as polyphenols, ﬂavonoid aglycones, phenolic acid and their
esters, caffeic acid and their esters and phenolic aldehydes and ke-
tones (Orsolic & Basic, 2003).
Recently, attention is being focused on the anti-cancer activity of
propolis. The studies, however, have been performed using etha-
nolic or hydroalcoholic extracts (Orsolic & Basic, 2003). Ethanolic
formulations of propolis prevent its consumption by people whoETEG: Rua Simeão Camargo
040 080, Brazil. Tel.: +55 042
s).
evier OA license. can not consume alcohol for medical reasons, such as diabetic
patients. Several patents have dealt therefore with new methods
or solvents besides ethanol to extract propolis (Kasuma & Kenichi,
2001a, 2001b; Namiki et al., 2005). These patents have reported
the use of edible vegetable oils, triglycerides and fatty acids as
extraction solvents for propolis. Data on the biological activity
and chemical composition of oil extracts of propolis are, however,
scarce. Tosi, Donini, Romagnoli, and Bruni (1996) evaluated the
antimicrobial activity of commercial extracts of propolis prepared
with different solvents including oils. They reported a wide range
of antimicrobial activity for the oil extract and concluded that the
solvent employed for the extraction of propolis inﬂuences the po-
tency of its antimicrobial activity. We have compared antiprolifer-
ative activity against the HL-60, MDAMB-435 and SF-295 cells lines
of oil and ethanolic propolis extracts (Buriol et al., 2009) and found
out that oil extracts were active against the tumour cell line tested
showing higher anticancer potential against the SF-295 cell line.
The aim of this study was to investigate the effects of the oil and
ethanolic extracts of propolis in experimental models. Hematolog-
ical, biochemical, histopathological and morphological analyses of
the tumour and the organs, including liver, spleen and kidney,
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ment. The results of this study should therefore advance the
knowledge of the antitumour beneﬁts of edible oil extracts of prop-
olis and provide a better understanding of their application in the
prevention/treatment of malignant tumours. Besides biological
assays, the oil extract of propolis was also fractioned by chroma-
tography and its fractions analysed using mass spectrometry to
evaluate their chemical composition.
2. Materials and methods
2.1. Propolis and extracts
2.1.1. Samples
Propolis samples were collected in 2006 and supplied by Camp-
olin and Schmidt Company from Prudentópolis city (Paraná State,
Brazil). Propolis was stored at 18 C until extraction.
2.1.2. Extracts
Fifty grams of propolis were extracted in a shaker with 500 ml
of canola oil or 70% ethanol, during 24 h, at room temperature.
After that period, the extractive solutions were ﬁltered. The solvent
was removed from the hydro-alcoholic solution yielding EEP70.
The oil extract of propolis was partitioned into 80% v/v metha-
nol/water and the aqueous methanolic phase was dried in a rota-
tory evaporator yielding ODEP.
2.2. Chromatography fractionation
Hundred and eighty milligrams of ODEP in methanol were ap-
plied on a glass column (3  80 cm) containing Sephadex LH-20.
The elution was performed with methanol. A total of 80 fractions
of 8 ml each were obtained. These fractions were joined in six
new fractions, labeled as OLSx 1–6, through thin layer chromatog-
raphy analyses on silica gel (mobile phase chloroform/acetone/ace-
tic acid 18:4:1 v/v/v and visualisation of spots at UV of 254 nm
with the use of FeCl3 as the colour reagent).
2.3. Mass spectrometry analyses
2.3.1. ESI()–MS data
Samples of OLSx 1–6 were analysed using a Q-Trap mass spec-
trometer (Applied Biosystems) with the direct infusion of the sam-
ple solutions into the electrospray ionisation source operating in
the negative ion mode. Capillary and cone voltages were set to
4500 V and 50 V, respectively, with a de-solvation temperature
of 100 C.
2.3.2. Liquid chromatographic mass spectrometry analyses (LC–MS)
OLSx 3–6 were introduced into an HPLC (Agillent) with a
lBondapak C18 analytical column (Waters, 3,9  300 mm,
10 lm) and detected in a Q-Trap mass analyser. ESI()–MS was
carried out with capillary and cone voltages set to 4500 and
50 V, respectively, and a de-solvation temperature of 300 C. A
binary mobile phase of acetonitrile and 1% of formic acid was em-
ployed. A linear gradient was performed starting from 30% of ace-
tonitrile to 100% acetonitrile, in 30 min, and an elution ﬂow rate of
1 ml/min.
2.3.3. ESI()–MS/MS
Tandem mass spectra were acquired using a hybrid high-reso-
lution and high-accuracy (5 ppm) Micromass Q-TOF mass spec-
trometer (Waters) and via collision-induced dissociation at ca.
15 V. Capillary and cone voltages were set to ±3000 and ±40 V,
respectively, for the negative or positive mode of ionisation. Thede-solvation temperature was 100 C; nitrogen and argon were
used as de-solvation or collision gas, respectively.
2.4. Biological assays
2.4.1. Cytotoxicity assays
The cytotoxicity of propolis extracts and fractions from ODEP
was evaluated against four human tumour cell lines: HL-60 (leuke-
mia), HCT-8 (colon), MDA/MB-435 (breast) and SF-295 (brain)
obtained from the National Cancer Institute (Bethesda, MD, USA).
The general viability of cultured cells was determined by the
reduction of the yellow dye 3-(4,5-dimethyl-2-thiazolyl)-2,5-di-
phenyl-2H-tetrazolium bromide (MTT) to a blue formazan product,
as previously described by Mosmann (1983).
The tumour cells were maintained in RPMI 1640 medium, sup-
plemented with 10% fetal bovine serum, 1% penicillin and strepto-
mycin at 37 C with 5% CO2. For all experiments cells were seeded
at 0.3  106 cells/ml (HL-60, MDA/MB-435 e SF-295) and
0.7  105 cells/ml (HCT-8), and incubated during 72 h with propo-
lis extracts (0.001–50 lg/ml ODEP and EEP70) and fractions
(0.001–25 lg/ml), under the conditions described above. After cen-
trifugation and solution removing, MTT solution was added and
the plates were incubated, centrifuged, and the solids dissolved
in pure and sterile DMSO. The absorbance was measured in a plate
spectrophotometer DTX-800 (Beckman Coulter) at 595 nm. Doxo-
rubicin (Sigma) was used as a positive control.
2.4.2. In vivo antitumoural assays
2.4.2.1. Animals. A total of 80 Swiss mice (male, 25–30 g), obtained
from the central animal house of Federal University of Ceará, Brazil,
were used. The animals were housed in cages with free access to
food and water (conforming to a well-deﬁned rodent diet). All ani-
mals were kept under a 12:12 h light–dark cycle (lights on at
6:00 a.m.). The animals were treated according to the ethic princi-
ples of animal experimentation of COBEA (Colégio Brasileiro de
Experimentação Animal), Brazil. The Animal Studies Committee
of the Federal University of Ceará approved the experimental
protocol.
Sarcoma 180 tumour cells were maintained in the peritoneal
cavities of the Swiss mice obtained from the central animal house
of the Federal University of Ceará.
2.4.2.2. Determination of the effect of propolis extract on tumour
growth in vivo. Ten-day-old sarcoma 180 ascites tumour cells
(2 ± 106 cell/500 ll) were implanted subcutaneously into the left
hind groin of the experimental mice. One day after inoculation,
the propolis extracts (50 and 80 mg/kg to ODEP and EEP70) or
5-FU (25 mg/kg) were dissolved in 4% DMSO and administered
intraperitoneally for 7 days. The negative control was injected with
4% DMSO. On day 8th, the mice were killed and the tumours were
excised, weighed and ﬁxed in 10% formaldehyde. The inhibition ra-
tio (%) was calculated by the following formula: inhibition ratio
(%) = [(A  B)/A]  100, where A is the average tumour weight of
the negative control, and B is the tumour weight of the treated
group.
2.4.3. Toxicological analysis
2.4.3.1. Effects of propolis extracts on organ and body weight. Deter-
mination of the effect of propolis extracts on the organ body
weights were measured at the beginning and at the end of the
treatment and the animals were observed for signs of abnormali-
ties throughout the study. The positions, shapes, sizes and colour
of internal organs, namely kidneys, liver and spleen were observed
for any signs of gross lesions. These organs were collected, weighed
and ﬁxed in 10% formaldehyde.
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parameters. After fasting for 6–8 h, the animals were submitted to
blood collection from the orbital plexus for biochemical analysis
(urea and creatinine to investigate any renal function alterations;
AST and ALT as liver parameter). The analysis was carried out in
a semi-automatic equipment (LabQuest), using enzymatic col-
ourimetric kits, while the hematological cells were quantiﬁed in
a Sysmex KX-21 N. The methodology of the LabQuest and Sysmex
equipment are based, respectively, on the principle of absorption
and impedance.
2.4.3.3. Determination of the effect of propolis extracts on hematolog-
ical parameters. After fasting for 6–8 h, the animals were submitted
to blood collection from the orbital plexus for hematological anal-
yses. The hematological analyses were performed by an optical
microscope Olympus BX 41. Hematological parameters, including
the hemoglobin content, platelet count, total count of leukocytes as
well as a differential count of leukocytes, such as eosinophil (%),
lymphocyte (%), neutrophil (%) and monocyte (%) were measured.
2.4.3.4. Histopathology and morphological observations. After being
ﬁxed with formaldehyde, tumours, livers, spleens and kidneys
were grossly examined for size or colour changes and hemorrhage.
Subsequently, portions of the tumour, liver, spleen and kidney
were cut into small pieces, followed by staining with hematoxylin
and eosin of the histological sections. Histological analyses were
performed by light microscopy. The occurrence and the extent of
liver or kidney lesions attributed to drugs were recorded.3. Results
3.1. Analysis of ODEP chemical composition by ESI()–MS, LC–MS
and LC–MS/MS
ODEP fractionation gave fractions OLSx 1–6, which were ﬁrst
analysed by direct infusion ESI()–MS. Since propolis is a rich nat-
ural bee product containing mainly phenolic compounds, such as
cinnamic acid derivatives and ﬂavonoids, ions were mostly pro-
duced by electrospray ionisation in the negative ion mode. ESI()
is a soft ionisation technique and mass spectra mainly detected
components as their intact deprotonated molecules. ESI()–MS
provides therefore ﬁngerprinting characterisation of propolis ex-
tracts via characteristic proﬁles of their chemical composition in
terms of the most polar and acidic or basic components (Sawaya
et al., 2004a, 2007).
Fig. 1 shows the ESI()–MS ﬁngerprints of ODEP fractions and
indicates great differences in the chemical composition between
the fractions. OLSx1 and OLSx2 were complex fractions with sev-
eral high to medium abundant ions, such as m/z 387, 311, 341
and 275 (OLSx1). For OLSx2, the highest abundant ions were those
of m/z 315, 339, with medium abundant ions of m/z 265, 325, 293
and 377. Fractions OLSx 3–6 were simpler and showed mostly a
single major ion. OLSx3 showed mostly the ions of m/z 247, 231,
301 and 393 whereas OLSx4 showed those of m/z 301, 245, 393
and 287 as most abundant. Fractions OLSx5 and OLSx6 showed a
major common ion of m/z 299 and other less abundant ions of m/
z 329 and 387 (OLSx5) and m/z 249, 285, 311 and 387 (OLSx6).
To characterise the fractions constituents, LC–MS and LC–MS/
MS were performed. Via comparisons with the fragmentation pat-
tern of previously identiﬁed compounds (Marcucci, Sawaya, Custo-
dio, Paulino, & Eberlin, 2008), several components have been
identiﬁed: 3,4-dihydroxi-5-prenyl-cinnamic acid (m/z 247, OLSx3);
dihydrokaempferide (m/z 301, OLSx3 and OLSx4); 3-prenyl-4-
hydroxicinnamic acid (m/z 231, OLSx3); (E)-3-{-4-hydroxy-3-[(E)-
4-(2,3-dihydrocinnamoyl oxy)-3-methyl-2-butenyl]-5-prenylphe-nyl}-2-propenoic acid (m/z 447, OLSx2). Isosakuranetin (m/z 285,
OLSx4 and OLSx6) was identiﬁed by comparison of its MS/MS frag-
mentation with a standard kindly provided by Vassya S. Bankova,
(Bulgarian Academy of Science). We have identiﬁed some of those
compounds previously in the oil extracts of propolis (Buriol et al.,
2009).
In addition, LC–MS identiﬁed two compoundswith the samem/z
299 but different retention time. Compound in OLSx2 with [M–H]
ofm/z 299 and tR 24 min showed in its ESI()–MS/MS a fragmenta-
tion to the ion ofm/z 255 via initial loss of 45 Da and ofm/z 244, 200
and 145. It was identiﬁed as 3,5-diprenyl-4-hydroxicinnamic acid
also known by artepellin C. ESI()–MS/MS of the other compound
with [M–H] of m/z 299 but tR 14 min in OLSx5 and OLSx6 under-
went fragmentation to the ion ofm/z 284 via initial loss of a methyl
radical andwas identiﬁed as kaempferide. Other fragment ions ofm/
z 164, 151, and 107 are typical of the cleavage of the ﬂavonoids cen-
tral C-ring (Cuyckens & Claeys, 2004) (Table 1).3.2. In vitro cytotoxicity assays
Table 2 shows the results from the in vitro cytotoxic assays for
the propolis extracts and the fractions obtained by the chromato-
graphic separation of ODEP on Sephadex LH-20. The extract of
propolis obtained with canola oil and dried (ODEP) displayed mod-
erate cytotoxicity against leukemia (HL-60), melanoma (MDA-MB-
435) and glioblastoma (SF-295) cancer cells, a better result than
the ethanolic extract (EEP70). When analysing cytotoxicity from
ODEP fractions, it was evident that the fractions were less active
than the propolis extract (ODEP) in the cell lines evaluated,
whereas OLSx4 and OLSx5 showed moderate cytotoxicity against
leukemia (HL-60) and colon (HCT-8).3.3. Effect of propolis extracts on tumour growth in vivo and on organ
and body weight
To check if the cytotoxic effects observed in vitro also occured
in vivo, we used the Sarcoma 180 (S-180) model which is a
mouse-originated tumour frequently used in in vivo antitumour re-
lated research (Gonzaga et al., 2009). Fig. 2 shows the effects of the
propolis extracts on mice transplanted with S-180 tumour. There
was a signiﬁcant reduction of the tumour weight in all extracts
tested. The differences between experimental groups were com-
pared by ANOVA followed by Student Newman Keuls or Bonferroni
tests (p < 0.05). On the 8th day, the average tumour weight of the
control mice inoculated with sarcoma 180 was 2.05 ± 0.22 g. In
the presence of EEP70, the sarcoma 180 weight was reduced to
0.94 ± 0.35 and 0.90 ± 0.22 g at doses of 50 and 80 mg/kg, respec-
tively. These reductions are equivalent to inhibition ratios of
53.94% and 56.29%. In the presence of ODEP, the sarcoma 180
weight was reduced to 0.92 ± 0.14 and 0.96 ± 0.24 g at doses of
50 and 80 mg/kg, respectively. These reductions are equivalent to
inhibition ratios of 54.94% and 53.35%. At 25 mg/kg, 5-FU reduced
tumour weight by 51.56% within the same period. These results
showed that the inhibition ratio of the ethanolic extract was the
same as that of oil extract and no differences were observed when
the extracts were tested at doses of 50 and 80 mg/kg. It was dem-
onstrated that both extracts of propolis inhibited the Sarcoma 180
tumour growth in mice.
After killing the animals, the organs were weighed. No signiﬁ-
cant changes in the organ weights were seen in any of the ex-
tract-treated animals (Fig. 2). After treatment with 5-FU,
however, the spleen weights were signiﬁcantly reduced when
compared with the control group (p < 0.05). No signiﬁcant gain in
body weight was seen among the groups (p > 0.05) (data not
shown).
Fig. 1. ESI()–MS ﬁngerprints from ODEP fractions.
Table 1
Identiﬁed compounds in fractions from the oil extract of propolis and ESI()–MS/MS fragments.
Compound Fraction tR m/z [M–H] Main fragments: m/z (relative abundance %)
4-Hydroxy-3-prenylcinnamic acid OLSx3 6,4 231 187 (50), 132 (100)
3,4-Dihydroxy-5-prenylcinnamic acid OLSx3 10,6 247 203 (100), 185 (10), 148 (55)
Isosakuranetin OLSx4
OLSx6
15 285 270 (10), 243 (20), 164 (100), 151 (20), 136 (20)
Kaempferide OLSx5
OLSx6
14 299 284 (100), 164 (10), 151 (20)
Artepillin C OLSx2 24 299 255 (30), 200 (100), 185 (10), 145 (10)
Dihydrokaempferide OLSx4
OLSx3
10,8 301 283 (50), 227 (30), 152 (100), 151 (30), 125 (40), 107 (20)
(E)-3-{-4-hydroxy-3-[(E)-4-(2,3-dihydrocinnamoyl oxy)-
3-methyl-2-butenyl]-5-prenylphenyl}-2-propenoic acid
OLSx2 20 447 297(100), 253 (10), 149 (90)
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Table 2
In vitro cytotoxic activity of propolis extracts and fractions against tumour cell lines.
Samples (lg/mL) IC50a
HL-60 HCT-8 MDA/MB-435 SF-295
EEP-70 25.22
25.67–33.72
>40 >40 >40
ODEP 26.87
23.27–31.02
>40 22.19
12.10–40.68
16.63
14.52–16.72
OLSx1 >25 >25 >25 >25
OLSx2 >25 >25 >25 >25
OLSx3 >25 >25 >25 >25
OLSx4 24.12
22.21–27.74
22.32
20.10–24.14
>25 >25
OLSx5 23.15
21.14–25.34
18.12
14.12–22.23
>25 >25
OLSx6 >25 >25 >25 >25
Doxorubicin 0,02
0,01–0,03
0,01
0,01–0,02
0,48
0,34–0,66
0,24
0,17–0,36
a Data are presented as IC50 values and 95% conﬁdence interval obtained by non-
linear regression for leukemia (HL-60), colon (HCT-8), breast (MDA-MB-435) and
brain (SF-295) cancer cells from two independent experiments performed four
times (n = 8).
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No signiﬁcant changes in the renal (urea and creatinine levels) or
liver [enzymatic activity of transaminases aspartate aminotransfer-
ase (AST) andalanineaminotransferase (ALT)]parameterswere seen
in the animals treatedwith propolis extracts (data compared by AN-
OVA followedbyStudentNewmanKeuls orBonferroni testsp< 0.05)
inmice transplantedwith Sarcoma 180 tumour (Fig. 3). The animals
treated with 5-FU have alteration on renal and liver parameters.3.5. Histopathology, morphological, and morphometric changes
Histopathological analyses of the tumours extirpated from the
control mice showed a malignant neoplasm composed of pleomor-
phic polygonal cells with little cytoplasm, some with vesicular nu-
clei, and acidophilic macronucleoli. Muscular invasion, areas of
coagulation necrosis and typical and atypical mitotic ﬁgures were
also observed. In the tumours extirpated from treated animals,
extensive areas of coagulative necrosis were observed.Fig. 2. Inhibition ratio on solid tumour and effThe histopathological analyses of livers, removed from all
groups, showed foci of microvesicular steatosis. Mild swelling of
hepatocytes and focal microvesicular steatosis were observed in
the negative control group. In 5-FU-treated animals intense cell
swelling of hepatocytes, microvesicular steatosis, hyperplasia of
Kupffer cells and hemosiderin were observed. In ODEP-treated ani-
mals, moderate swelling cell hepatocyte, microvesicular steatosis,
hyperplasia of Kupffer cells, inﬂammatory foci and bilirubin were
observed. In EEP70-treated animals we found intense swelling of
hepatocytes and large areas of microvesicular steatosis.
Analyses of the kidneys showed cilindrohialin, which indicates
a difﬁculty of the renal ﬁltration system of proteins. Severe swell-
ing of the tubular epithelium was also found in all groups, includ-
ing the 5-FU. All groups showed lymphoid follicles in the spleen,
sometimes with large, irregular, ill-deﬁned borders, probably re-
lated to the actual tumour (sarcoma 180) that leads to this histo-
logical ﬁnding. All groups showed areas of hemorrhage.
3.6. Effect of the propolis extracts on hematological parameters
The animals transplanted with Sarcoma 180 tumours treated
with 5-FU showed a strong reduction on the total leukocytes
(p < 0.05). Treatment with the propolis extracts demonstrated no
alteration (Table 3).4. Discussions
ESI()–MS, LC–MS and LC–MS/MS identiﬁed several prenylated
phenolic acids and ﬂavonoids in ODEP, demonstrating that vegeta-
ble oil was able to extract important bioactive natural phenolic
compound from crude propolis. Compounds identiﬁed in the pres-
ent work have been found in alcoholic and hydro-alcoholic extracts
of propolis from Brazil and other countries and are related to many
biological activities (Banskota, Tezuka, & Kadota, 2001; Banskota
et al., 1998; Lustosa, Galindo, Nunes, Randau, & Neto, 2008; Sa-
waya, Souza, Marcucci, Cunha, & Shimizu, 2004; Sawaya et al.,
2002b). This is so for artepillin C, for instance, a major compound
in green Brazilian propolis, for which biological activities, such as
antimicrobial, antioxidant and anti-tumour, as well as increases
in the immune response against leukemia have been reported (Shi-
mizu, Ashida, Matsuura, & Kanazawa, 2004). Because of these bio-ect of propolis extracts on organ weights.
Fig. 3. Effect of propolis extracts on biochemical parameters in peripheral blood from mice transplanted with sarcoma 180 tumour.
Table 3
Effect of propolis extracts on the hematological changes on peripheral blood.
Drug Dose mg/kg Hemoglobin (g/dl) Platelets (106 cel/ll) Leukocytes (106 cel/ll) Differential count (%)
Eosinophils Neutrophils Lymphocytes Monocytes
Salina – 12.26 ± 0.31 1240 ± 119 4.1 ± 0.31 0 44 36.00 8
5-FU 25 10.30 ± 0.20 934 ± 54a 1.2 ± 0.21a 0 52 37.00 7
EEP70 50 13.01 ± 0.40 1243 ± 55 3.96 ± 0.40 0.2 47 35.00 9
80 14.02 ± 0.50 1244 ± 45 3.87 ± 0.30 0.1 45 34.00 8
ODEP 50 12.08 ± 0.49 1343 ± 105 3.12 ± 0.34 0 39 36.60 8
80 11.76 ± 0.52 1454 ± 109 4.15 ± 1.22 0 40 35.40 7
Data are presented as mean ± SEM.
a The differences between experimental groups were compared by ANOVA followed by Student Newman Keuls or Bonferroni tests (p < 0.05).
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ered as a high quality propolis and the content of artepillin C is al-
ready used in quality control by some companies (Funari & Ferro,
2006). By visual inspections of the chromatograms (data not
shown), from both LC–MS and LC–UV (PDA), it was evident that
artepillin C is commonly present in propolis from Prudentópolis,
and that the oil extracts of propolis do contain signiﬁcant levels
of prenylated phenolic acids, including artepillin C. Several other
ions in the oily extract of propolis remained unknown indicating
the need to carry on further studies of the chemical composition
of this promising ODEP extract.
All treatment regimens for the majority of cancers produce side
effects, which makes this treatment extremely unpleasant for
patients. Scientists have spent therefore efforts to develop new
therapies for the treatment of cancer. Propolis has been a subject
of intense research, especially in the areas of anticancer research
(Banskota et al., 2000; El-khawaga Om-Ali, Tarek, & Mohammed,
2003; Padmavathi, Senthilnathan, Chodon, & Sakthisekaran,
2006). The majority of those studies evaluated the ethanol, aque-
ous or methanol extracts of propolis, hence in this work we as-
sessed the antitumour effect of an oil extract of propolis. We
have previously reported data comparing antiproliferative activity
against HL-60, MDAMB-435 and SF-295 cells lines of oil and etha-
nolic propolis extracts (Buriol et al., 2009). Because a different
sample of propolis (but from the same region) and different condi-
tions extractions were used, we can not directly compare the IC50
value reported earlier with the present values, but in both investi-
gations the oil extracts of propolis were active against the tested
tumour cell lines indicating more anticancer potential against theSF-295 cell line than the ethanolic extracts. The present results
show that the oil extract of propolis has substances with cytotoxic
effects similar to the more common ethanolic extracts, making this
extract attractive for applications where ethanol must be avoided.
The oil extract of propolis also produced better inhibition of
tumour cells than its fractions, indicating that propolis cytotoxic
activity is probably a ‘‘shotgun’’ synergic effect of its many bioac-
tive components. The biological activity of propolis should there-
fore be highly depended on the extraction process.
In the Sarcoma 180 model assay it was demonstrated that all
propolis extracts inhibited tumour growth in mice with the same
inhibition ratio as the positive control 5-FU but with less side
effects.
The histopathological analyses of organs removed from treated
animals showed that the treatment with 5-FU, ODEP and EEP70 led
to Kupffer cell hyperplasia and necrosis, which signals the presence
of a toxic agent. Nevertheless, these alterations could be consid-
ered reversible (Kummar, Abbas, & Fausto, 2004; Scheuer & Lefko-
witch, 2000).
Renal parameters were also evaluated. The histopathological
analyses of the kidneys showed focal areas of necrosis in the tubu-
lar epithelium in all groups of treatment, suggesting that the treat-
ment with 5-FU, ODEP and EEP70 caused kidney damage. Necrosis
of the renal tubule epithelium may occur on a large scale as a con-
sequence of the administration of different chemical classes (Olsen
& Solez, 1994). Although modiﬁcations of kidney tissues were
observed, the analysis of biochemical parameters didn’t show
changes in levels of urea and creatinine. Nevertheless, blood urea
was increased only a long time after renal alteration, which may
A.A. Carvalho et al. / Food Chemistry 126 (2011) 1239–1245 1245explain why the treatment in this study failed to induce any alter-
ation in the blood urea levels.
Separately from hepatotoxic and nephrotoxic effects, anticancer
drugs also produce delayed hematopoietic depression, as observed
in treatment with methotrexate and 5-FU (Bezerra et al., 2008;
Katzung, 2003). In fact, most chemotherapeutic drugs, including
5-FU, are immunosuppressive because they kill many normal cells
as well as tumour cells (Bezerra et al., 2008; Takiguchi et al., 2001)
and have negative side effects. One of the risks of radiation and
chemotherapy in the treatment of cancer patients is the develop-
ment of leukopenia, which substantially increases the risk of infec-
tions. We observed herein leukopenia in the 5-FU treatment, but
not in the EEP70 and ODEP treatment.
The weight of the spleens in animals treated with 5-FU was also
signiﬁcantly lower than in the control group, which also indicated
an immunosuppressive side effect of 5-FU, but propolis treatment
caused no alteration in the weight of the spleen. When comparing
the histopathological analyses, we observed that all groups treated
with propolis showed congestion on red pulp, which indicates a
possible effect on the immodulatory system. It is well reported that
the mechanism of antitumour effects elicited by propolis extracts
has been attributed to its effect on the immodulatory system.5. Conclusions
The ﬁndings in the present study indicate the potential of oil
extract of propolis for the treatment of cancer. The ethanol-free
vegetable oil extract of propolis displayed important in vitro and
in vivo antitumour effects due to a synergic effect of its many bio-
active constituents with moderate signs of toxicity.
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